期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Translational Cancer Research LetPub Score 5.3
50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 7.1 | ||||||||||||||||||||||||
期刊簡稱 | TRANSL CANCER RES | ||||||||||||||||||||||||
ISSN | 2218-676X | ||||||||||||||||||||||||
E-ISSN | 2219-6803 | ||||||||||||||||||||||||
h-index | 22 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 6.70%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://tcr.amegroups.com/ | ||||||||||||||||||||||||
在線稿件提交 | http://tcr.amegroups.com/login?source=%2Fauthor%2Fsubmit | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | AME Publishing Company | ||||||||||||||||||||||||
主題領域 | ONCOLOGY | ||||||||||||||||||||||||
出版國/地區 | PEOPLES R CHINA | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 261每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 99.74% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2218-676X%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[Translational Cancer Research] 的評論 | 撰寫評論 |
作者: 靖烟少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-29 15:19:11 評論於 I applied on March 30th and I have been at step 4 ever since(0) 讚! | 靖烟少爷 |
作者: 橙子GO 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-23 15:29:17 評論於 May I ask what the current result is? Have I been hired?(0) 讚! | 橙子GO |
作者: amyi 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-18 09:28:58 評論於 The relationship is still good, I communicated with the editor, and got accepted in three months(0) 讚! | amyi |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-13 14:49:15 評論於 同问 Can you translate the following paragraph into English and Japanese and title each translation with ":" and ":"?(0) 讚! | 伏象小烟 |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-10 22:15:27 評論於 Please translate the following paragraph into English and Japanese, and use ":" and ":" as the titles: 同问!(0) 讚! | 伏象小烟 |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-10 16:54:33 評論於 Will I receive a receipt letter from the magazine publisher after making the payment?(0) 讚! | 伏象小烟 |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-10 16:49:10 評論於 Did you receive a confirmation email after submitting the payment screenshot as requested? I have not received one(0) 讚! | 伏象小烟 |
作者: 墟散剑博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-09 21:44:38 評論於 How are you doing, brother?(0) 讚! | 墟散剑博 |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-09 12:14:27 評論於 Accepted(0) 讚! | 伏象小烟 |
作者: 是你的宏盛呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-21 14:32:32 評論於 My second round of peer review has been over 2 months, feeling anxious about graduation(0) 讚! | 是你的宏盛呀 |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 11:08:04 評論於 I'm not sure, I've been here fixing it all along(0) 讚! | 伏象小烟 |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 09:30:13 評論於 I am also in STEP 5 after the major overhaul, it has been 20 days and no news, should I send an email?(0) 讚! | 伏象小烟 |
作者: 东京绮烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-11 19:10:03 評論於 Received a sudden notification from Xiaoxiu today, so excited(0) 讚! | 东京绮烟 |
作者: 伏象小烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-11 08:28:40 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Overemphasized research direction: tumor experience sharing: Stayed at step 5 for 20 days after major revision, no news, what should I do?(0) 讚! | 伏象小烟 |
作者: 东京绮烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-10 10:24:26 評論於 I have been at step 4 since submitting my manuscript, and I have not received any feedback from the reviewers yet(0) 讚! | 东京绮烟 |
作者: 赫莫萨西尼尔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-09 15:19:05 評論於 Have you been staying at Step 4 ever since the major renovation?(0) 讚! | 赫莫萨西尼尔 |
作者: 磐石 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-04-07 12:24:00 評論於 It took 4 months to finally publish it, I won't play with bioinformatics anymore, almost broke my hands(1) 讚! | 磐石 |
作者: 东京绮烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-31 11:01:21 評論於 Main research focus: Pan-cancer research; Monogenic; Sharing experience in bioinformatics research: Submitted manuscript in January, still stuck at step 4, what's going on?(0) 讚! | 东京绮烟 |
作者: 削月金鑫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-14 19:20:47 評論於 At least it is SCI, we will get higher with more submissions, keep it up!(0) 讚! | 削月金鑫 |
作者: Oliver Hazlitt 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-12 14:28:30 評論於 The minor revision will be completed on December 18, 2023 and accepted on January 19, 2024. It is now online(0) 讚! | Oliver Hazlitt |
作者: Oliver Hazlitt 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-12 11:41:39 評論於 The editors of this journal take language, description, grammar, and formatting very seriously and hope that it will continue to improve, so that we can also benefit(0) 讚! | Oliver Hazlitt |
作者: 东京绮烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-11 19:49:01 評論於 The submission webpage won't open(0) 讚! | 东京绮烟 |
作者: 东京绮烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-11 09:52:40 評論於 I can't access the journal website recently(0) 讚! | 东京绮烟 |
作者: 削月金鑫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-07 11:48:00 評論於 R3 has started, how are you doing now?(0) 讚! | 削月金鑫 |
作者: 魔都绍懿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-05 13:53:05 評論於 It's indeed difficult(0) 讚! | 魔都绍懿 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us